These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34399162)

  • 21. Impulse control and related disorders in Parkinson's disease.
    Weintraub D; Nirenberg MJ
    Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
    Voon V; Potenza MN; Thomsen T
    Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced impulse control disorders: a review.
    Atmaca M
    Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
    Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
    Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
    Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
    Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex, drugs and Parkinson's disease.
    Ushe M; Perlmutter JS
    Brain; 2013 Feb; 136(Pt 2):371-3. PubMed ID: 23413258
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study.
    Fusaroli M; Giunchi V; Battini V; Gringeri M; Rimondini R; Menchetti M; Radice S; Pozzi M; Nobile M; Clementi E; De Ponti F; Carnovale C; Raschi E; Poluzzi E
    Psychiatry Clin Neurosci; 2023 Mar; 77(3):160-167. PubMed ID: 36436204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's Disease and other disorders.
    Raja M; Bentivoglio AR
    Curr Drug Saf; 2012 Feb; 7(1):63-75. PubMed ID: 22663960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impulse control disorders in Parkinson's disease: a psychosocial perspective.
    Delaney M; Leroi I; Simpson J; Overton PG
    J Clin Psychol Med Settings; 2012 Sep; 19(3):338-46. PubMed ID: 22581074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine and impulse control disorders in Parkinson's disease.
    Weintraub D
    Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced impulse control disorders in Parkinson's disease.
    Reiff J; Jost WH
    J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
    Kon T; Ueno T; Haga R; Tomiyama M
    Brain Behav; 2018 Aug; 8(8):e01036. PubMed ID: 29956879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson's Disease.
    Kwan C; Kolivakis T; Huot P
    Can J Neurol Sci; 2023 Sep; 50(5):779-780. PubMed ID: 35801613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.